These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 3422078)
1. Human platelet alpha granules contain a nonspecific inhibitor of megakaryocyte colony formation: its relationship to type beta transforming growth factor (TGF-beta). Mitjavila MT; Vinci G; Villeval JL; Kieffer N; Henri A; Testa U; Breton-Gorius J; Vainchenker W J Cell Physiol; 1988 Jan; 134(1):93-100. PubMed ID: 3422078 [TBL] [Abstract][Full Text] [Related]
2. Differential proliferative effects of transforming growth factor-beta on human hematopoietic progenitor cells. Ottmann OG; Pelus LM J Immunol; 1988 Apr; 140(8):2661-5. PubMed ID: 3258618 [TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of highly purified human platelet beta-thromboglobulin on in vitro human megakaryocyte colony formation. Abgrall JF; Han ZC; Sensebe L; Le Gall G; Guern G; Renard I; Briere J Exp Hematol; 1991 Mar; 19(3):202-5. PubMed ID: 1825299 [TBL] [Abstract][Full Text] [Related]
4. Suppression of maturation of megakaryocyte colony forming unit in vitro by a platelet-released glycoprotein. Dessypris EN; Gleaton JH; Sawyer ST; Armstrong OL J Cell Physiol; 1987 Mar; 130(3):361-8. PubMed ID: 3558491 [TBL] [Abstract][Full Text] [Related]
5. Differential effects of transforming growth factor-beta 1 on distinct developmental stages of murine megakaryocytopoiesis. Jackson H; Williams N; Westcott KR; Green R J Cell Physiol; 1994 Nov; 161(2):312-8. PubMed ID: 7962115 [TBL] [Abstract][Full Text] [Related]
6. Serum-free medium allows the optimal growth of human megakaryocyte progenitors compared with human plasma supplemented cultures: role of TGF beta. Berthier R; Valiron O; Schweitzer A; Marguerie G Stem Cells; 1993 Mar; 11(2):120-9. PubMed ID: 7681339 [TBL] [Abstract][Full Text] [Related]
7. [Platelet factor 4 acts as both inhibitor and protector of hematopoietic precursor cells: possible mechanism of action]. Han ZC; Zhang XJ; Xi XD; Lu M; Jiang S; Jiang LZ; Wang XM; Gu GL; Caen JP Shi Yan Sheng Wu Xue Bao; 1995 Dec; 28(4):415-26. PubMed ID: 8731973 [TBL] [Abstract][Full Text] [Related]
8. Differential effect of erythropoietin and GM-CSF on megakaryocytopoiesis from primitive bone marrow cells in serum-free conditions. Cardier JE; Erickson-Miller CL; Murphy MJ Stem Cells; 1997; 15(4):286-90. PubMed ID: 9253112 [TBL] [Abstract][Full Text] [Related]
9. Effects of in vivo administration of stem cell factor on thrombopoiesis in normal and immunodeficient mice. Chow FP; Zsebo K; Hamburger AW Exp Hematol; 1993 Aug; 21(9):1255-62. PubMed ID: 7687220 [TBL] [Abstract][Full Text] [Related]
10. New insights into the regulation of human megakaryocytopoiesis. Hoffman R; Straneva J; Yang HH; Bruno E; Brandt J Blood Cells; 1987; 13(1-2):75-86. PubMed ID: 3499196 [TBL] [Abstract][Full Text] [Related]
11. GpIIb/IIIa+ subpopulation of rat megakaryocyte progenitor cells exhibits high responsiveness to human thrombopoietin. Kato T; Horie K; Hagiwara T; Maeda E; Tsumura H; Ohashi H; Miyazaki H Exp Hematol; 1996 Aug; 24(10):1209-14. PubMed ID: 8765496 [TBL] [Abstract][Full Text] [Related]
12. Human bone marrow stromal cell colonies: response to hydrocortisone and dependence on platelet-derived growth factor. McIntyre AP; Bjornson BH Exp Hematol; 1986 Oct; 14(9):833-9. PubMed ID: 3019748 [TBL] [Abstract][Full Text] [Related]
13. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation. Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941 [TBL] [Abstract][Full Text] [Related]
14. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood. Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449 [TBL] [Abstract][Full Text] [Related]
15. [Platelet factor 4, reversible inhibitor of megakaryocytogenesis, protector of megakaryocytes during chemotherapy]. Caen JP; Xi X; Aidoudi S; Fournier S; Schlegel N; Bellucci S; Han ZC Bull Acad Natl Med; 1995 Nov; 179(8):1657-70. PubMed ID: 8717183 [TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta 1 (TGF-beta 1) and recombinant human tumor necrosis factor-alpha reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-derived TGF-beta 1 and TGF-beta 2, and recombinant human TGF-beta 1. Espevik T; Figari IS; Ranges GE; Palladino MA J Immunol; 1988 Apr; 140(7):2312-6. PubMed ID: 3280680 [TBL] [Abstract][Full Text] [Related]
17. Regulation of colony-stimulating factor 1-dependent macrophage precursor proliferation by type beta transforming growth factor. Strassmann G; Cole MD; Newman W J Immunol; 1988 Apr; 140(8):2645-51. PubMed ID: 3258617 [TBL] [Abstract][Full Text] [Related]
18. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro. Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899 [TBL] [Abstract][Full Text] [Related]
19. Megakaryocyte colony growth-supporting activities in human plasma: modification by platelets and platelet membranes. Yamasaki K; Jamal N; Mann KG; Messner HA J Cell Physiol; 1987 Nov; 133(2):337-43. PubMed ID: 3500177 [TBL] [Abstract][Full Text] [Related]
20. Physiologic role of TPO in thrombopoiesis. Miyazaki H Stem Cells; 1996; 14 Suppl 1():133-8. PubMed ID: 11012213 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]